In vitro experiments showed the ability of CagA-positive Helicobacter species to increase levels of the anti-apoptotic factor Bcl2 and activate NF-kB signaling pathways in co-cultured CCA cells, with the proliferation of bile duct cancer cells [72]. The gene discussed is S100A8; the disease is cholangiocarcinoma.